New Zealand markets closed

Eli Lilly and Company (LLY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
584.04-7.00 (-1.18%)
At close: 04:00PM EST
586.00 +1.96 (+0.34%)
After hours: 07:59PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
32,072,500
28,541,400
28,318,400
24,539,800
22,319,500
Cost of revenue
6,842,300
6,629,800
7,312,800
5,483,300
4,721,200
Gross profit
25,230,200
21,911,600
21,005,600
19,056,500
17,598,300
Operating expenses
Research development
8,746,600
7,190,800
7,025,900
6,085,700
5,595,000
Selling general and administrative
6,748,800
6,440,400
6,431,600
6,121,200
6,213,800
Total operating expenses
15,495,400
13,631,200
13,457,500
12,206,900
11,808,800
Operating income or loss
9,734,800
8,280,400
7,548,100
6,849,600
5,789,500
Interest expense
431,700
331,600
339,800
359,600
400,600
Total other income/expenses net
-3,315,500
-1,205,200
-1,078,200
706,900
-203,400
Income before tax
6,142,200
6,806,400
6,155,500
7,229,900
5,265,900
Income tax expense
1,153,800
561,600
573,800
1,036,200
628,000
Income from continuing operations
4,988,400
6,244,800
5,581,700
6,193,700
4,637,900
Net income
4,988,400
6,244,800
5,581,700
6,193,700
8,318,400
Net income available to common shareholders
4,988,400
6,244,800
5,581,700
6,193,700
8,318,400
Basic EPS
7.21
6.93
6.15
6.82
8.93
Diluted EPS
7.18
6.90
6.12
6.79
8.89
Basic average shares
900,886
901,736
906,963
907,634
931,059
Diluted average shares
903,919
904,619
911,681
912,505
935,684